Hypermethylation of GSTP1 was identified in 75/79 (94.94%) tumours, 10/14 (71.43%) HGPIN, 5/39 (12.82%) histologically normal prostate samples and 4/37 (10.81%) BPH. The gene discussed is GSTP1; the disease is benign prostatic hyperplasia.